Moisés de Oliveira Pontes Filho

Moisés de Oliveira Pontes Filho

Auto-generated profile, based on publicly available information

Moisés de Oliveira Pontes Filho

Laboratory of Environmental Mutagenesis, Department of Biophysics and Biometry, Institute of Biology Roberto Alcantara Gomes , Blvd. 28 de Setembro, 87, fundos, PAPC, 4º Andar, DBB - Laboratório 1, CEP: 20551-030, Rio de Janeiro State University, UERJ, Rio de Janeiro

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2026 in Mutagenesis
Verified
Journal Article
Closed access
PDF file
ECEduardo Kennedy Carrão-Dantas
Eduardo Kennedy Carrão-Dantas
JTJoão Pedro Franco Tabanela Thomé
João Pedro Franco Tabanela Thomé
MFMoisés de Oliveira Pontes Filho
Moisés de Oliveira Pontes Filho
MCMarsen Garcia Pinto Coelho
Marsen Garcia Pinto Coelho
IFIsrael Felzenszwalb
Israel Felzenszwalb
CLCarlos Fernando Araújo Lima
Carlos Fernando Araújo Lima
Popular ergogenic supplements for weight loss raise safety concerns due to potential cardiovascular, liver, and kidney toxicity. Their genotoxicity remains insufficiently studied, highlighting the need for more research on their long-term effects. The Brazilian health surveillance and regulatory system does not include dietary supplements under OECD genotoxicity regulatory guidelines. This study evaluates the mutagenic, cytotoxic, and genotoxic effects of a multi-herbal ergogenic supplement using the Ames test, WST-1 cell viability assay, and cytokinesis-block micronucleus tests in HepG2 and HEK293 cell lines. The Ames test revealed dose-dependent mutagenicity, particularly with metabolic activation, while the WST-1 assay showed hepatocytotoxic and nephrocytotoxic potential with dose- and time-dependent response. The cytokinesis-block micronucleus assay further confirmed genotoxicity, with significant formation of micronuclei and other cellular damage indicators. Our study emphasizes the need for careful safety monitoring of ergogenic supplements, highlighting the toxicity risks associated with their mutagenic, cytotoxic, and genotoxic potential.